These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16111286)

  • 21. [Chronic HBsAg-negative liver disease. Presence of the markers of hepatitis B virus (HBV) infection and their possible meaning].
    Diodati G; Pontisso P; Pornaro E; Stenico D; Bonetti P; Realdi G; Ruol A
    Ann Ital Med Int; 1987; 2(3):195-200. PubMed ID: 3275282
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Profiles of serological markers of HBV-infection in acute hepatitis B].
    Nikiforov ND; Sanin BI; Nikiforova GS; Saiapina ES; Novikova LV; Il'inskii IA; Popov AF
    Klin Med (Mosk); 1996; 74(7):16-8. PubMed ID: 8992103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 25. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
    Marignani M; Marzano A
    J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
    [No Abstract]   [Full Text] [Related]  

  • 26. [Markers of hepatitis B virus in chronic liver diseases].
    Maleev A; Ognianov M; Ninova D
    Ter Arkh; 1987; 59(7):13-7. PubMed ID: 3672351
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serologic markers of hepatitis B virus. Recent progress].
    Mora Pérez I; Porres Cubero JC; Carreño García V
    Rev Clin Esp; 1984 Apr; 173(1):9-14. PubMed ID: 6330799
    [No Abstract]   [Full Text] [Related]  

  • 28. Serological and molecular testing in hepatitis B and the dialysis patient.
    Fabrizi F; Lunghi G; Martin P; Poordad FF
    Int J Artif Organs; 2002 Feb; 25(2):91-9. PubMed ID: 11905519
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical Evaluation of the Newly Developed HISCL-5000 Analyzer on Detection of Hepatitis B Virus Markers in West China Hospital.
    Feng S; Wei B; Rao C; Wang T; Xiao Y; Tao C; Wang L
    Clin Lab; 2016; 62(6):1053-60. PubMed ID: 27468567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the appropriateness of hepatitis B serology testing prescribed by general practitioners in a selected area of southern Italy.
    Miragliotta G; Santacroce L; Vinci E
    J Eval Clin Pract; 2007 Oct; 13(5):823-5. PubMed ID: 17824880
    [No Abstract]   [Full Text] [Related]  

  • 31. [Detection of hepatitis B core antigen and antibody].
    Chayama K
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):253-7. PubMed ID: 12442394
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers.
    Shidrawi R; Ali Al-Huraibi M; Ahmad Al-Haimi M; Dayton R; Murray-Lyon IM
    J Med Virol; 2004 Aug; 73(4):562-5. PubMed ID: 15221900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL; Wend U; Candotti D; Foster GA; Hollinger FB; Dodd RY; Allain JP; Gerlich W
    N Engl J Med; 2011 Jan; 364(3):236-47. PubMed ID: 21247314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
    Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
    [No Abstract]   [Full Text] [Related]  

  • 36. Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification.
    Boyd A; Maylin S; Moh R; Gabillard D; Menan H; Mahjoub N; Danel C; Anglaret X; Eholié SP; Girard PM; Zoulim F; Delaugerre C; Lacombe K;
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):248-51. PubMed ID: 26283522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis B virus genotypes and mutations in asymptomatic carriers].
    Orito E; Mizokami M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():233-7. PubMed ID: 15453321
    [No Abstract]   [Full Text] [Related]  

  • 38. Appearance of HbeAg in an occult persistent hepatitis B virus infection.
    Paparella C; De Rosa F; Longo R; Cappiello G; Ursitti A; Rosa M; Morosetti M; Spanò A
    Intervirology; 2010; 53(3):173-5. PubMed ID: 20130415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nucleic acid-based testing for hepatitis B viruss infectious disease].
    Tanaka Y; Mizokami M
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():331-7. PubMed ID: 16416814
    [No Abstract]   [Full Text] [Related]  

  • 40. Seroprevalence of markers for hepatitis B viral infection.
    Merrill RM; Hunter BD
    Int J Infect Dis; 2011 Feb; 15(2):e78-121. PubMed ID: 21130675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.